omniture
深圳康泰生物制品股份有限公司 KANGTAI BIOLOGICAL

Latest News

Cooperation Agreement Concluded between BioKangtai and Biotis

-- Indicating Technology Transfer of the World's First Dual-carrier 13-valent Pneumococcal Conjugat...

2023-04-07 10:41 3773

Licensing and Agency Agreement Signed between Beijing Minhai (Biokangtai) and Phil. Pharmawealth, Inc.

Marks the First Entry of Biokangtai's 13-valent Pneumococcal Vaccine into Southeast Asian Market S...

2022-08-31 17:05 1773

BIOKANGTAI Signs a Cooperation Agreement with the Largest Importer of Parenteral Products in Philippines

SHENZHEN, China, March 21, 2022 /PRNewswire/ -- On March 17, 2022, Shenzhen Kangtai Biological Prod...

2022-03-21 22:22 1925

Kangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported for the First Time

SHENZHEN, China, Nov. 19, 2021 /PRNewswire/ -- At 3 a.m. on November 19, the first batch of more th...

2021-11-19 18:52 1686

BioKangtai's adenovirus vector COVID-19 vaccine obtained EUA in Indonesia

SHENZHEN, China, Nov. 3, 2021 /PRNewswire/ -- As reported by Indonesian National Agency of Drug and...

2021-11-03 19:02 1589

Biokangtai: Recombinant COVID-19 Vaccine(Adenovirus Vector) licensed for manufacturing, which actively promotes vaccine export and improves vaccine accessibility

SHENZHEN, China, Sept. 8, 2021 /PRNewswire/ -- The other day Shenzhen Kangtai Biological Products C...

2021-09-09 11:40 3487

BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines

SHENZHEN, China, Aug. 2, 2021 /PRNewswire/ -- On July 30, Shenzhen Kangtai Biological Products Co.,...

2021-08-02 15:25 5162

Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia

SHENZHEN, China, June 22, 2021 /PRNewswire/ -- On June 21, local time, phase III clinical fieldwork...

2021-06-22 22:32 9431